Dietary Reporting In The Amyloidoses
ConditionAmyloidosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBarbara Ann Karmanos Cancer Institute
About this trial
The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis.
The main question it aims to answer is:
Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients
Participants will be asked to:
* Download the MyFitnessPal application on their smartphone and view an online tutorial * After a week of practice, from weeks 2-9, participants will enter daily dietary intake as well as daily herbal/alternative supplement intake into the MyFitnessPal application on their smartphone. * complete a questionnaire prior to starting the application, after week 2 and at week 10 after starting the application
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years of age or older
Diagnosed with any type of amyloidosis
Speak, read and write in English
Willing to use the MyFitnessPal app on their own smartphone
Disqualifiers
a planned autologous stem cell transplant or a solid organ transplant in the 12 weeks after enrollment
cognitive or perceptual disturbances
Trial design
Design model
Single group
Treatments tested in this trial
Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)
Other interventionAmyloidosis patients will use MyFitnessPal application to track dietary intake and use of herbal/alternative supplements in from week 2-9. Patient's usage of the application and questionnaires completed by the patient at the start, Week 2 and Week 10 will determine feasibility.
Treatment groups
40 Participants
are divided into 1 treatment groupGroup A: Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)Other 1 intervention
Trial outcomes
Primary outcomes
1
Adherence Rate
The adherence is defined by the status (yes vs. no) of data recording per day; The adherence rate will be calculated by the ratio of the number of days of adherence to the total number of days of trial (i.e., 56 days); The status of data recording per day will be considered 'yes' if the participant completes a daily survey.
Time frame
56 daysSecondary outcomes
1
Subsequent adherence rate
The subsequent adherence is the status of data recording per day during the third phase (Week 10) of trial participation (i.e., 7 days); The subsequent adherence rate will be calculated by the ratio of the number of days of adherence during the third phase (Week 10) of trial participation (i.e., 7 days); The status of data recording per day will be considered 'yes' if the participant completes a daily survey.
Time frame
63 days (= 56 days + Week 10)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov